TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | 0.0% | 594 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +10.0% | 594 | -8.8% | 0.00% | -33.3% |
| Q1 2020 | $10,000 | -16.7% | 651 | +9.6% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +20.0% | 594 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $10,000 | -9.1% | 594 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | -8.3% | 594 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $12,000 | – | 594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |